Huntington National Bank Has $2.25 Million Stock Holdings in The Clorox Company (NYSE:CLX)

Huntington National Bank lifted its holdings in shares of The Clorox Company (NYSE:CLX) by 4.2% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,786 shares of the company’s stock after acquiring an additional 559 shares during the period. Huntington National Bank’s holdings in Clorox were worth $2,246,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Insight Folios Inc raised its stake in shares of Clorox by 3.0% in the third quarter. Insight Folios Inc now owns 2,195 shares of the company’s stock worth $358,000 after purchasing an additional 63 shares during the last quarter. Fiduciary Group LLC raised its position in Clorox by 0.4% in the 2nd quarter. Fiduciary Group LLC now owns 19,050 shares of the company’s stock valued at $2,600,000 after buying an additional 72 shares during the last quarter. GHP Investment Advisors Inc. lifted its stake in Clorox by 2.0% during the 2nd quarter. GHP Investment Advisors Inc. now owns 3,634 shares of the company’s stock valued at $496,000 after acquiring an additional 72 shares in the last quarter. SPC Financial Inc. boosted its holdings in Clorox by 2.2% during the 2nd quarter. SPC Financial Inc. now owns 3,485 shares of the company’s stock worth $476,000 after acquiring an additional 75 shares during the last quarter. Finally, Massmutual Trust Co. FSB ADV grew its stake in shares of Clorox by 17.2% in the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $83,000 after acquiring an additional 75 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.

Insider Buying and Selling

In other news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now directly owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. 0.57% of the stock is currently owned by insiders.

Clorox Trading Up 1.2 %

Shares of Clorox stock opened at $167.69 on Friday. The company has a debt-to-equity ratio of 11.08, a quick ratio of 0.62 and a current ratio of 1.00. The stock has a market capitalization of $20.76 billion, a P/E ratio of 58.43, a P/E/G ratio of 3.06 and a beta of 0.41. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $169.09. The stock’s 50-day simple moving average is $162.39 and its 200 day simple moving average is $147.34.

Clorox (NYSE:CLX) last announced its quarterly earnings results on Wednesday, October 30th. The company reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.64 billion. During the same period in the prior year, the company posted $0.49 EPS. Clorox’s revenue was up 27.0% compared to the same quarter last year. As a group, research analysts anticipate that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Investors of record on Wednesday, October 23rd were paid a dividend of $1.22 per share. The ex-dividend date was Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.91%. Clorox’s payout ratio is 170.04%.

Wall Street Analyst Weigh In

Several research firms recently weighed in on CLX. BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Evercore ISI cut their target price on Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a research note on Monday, October 14th. Jefferies Financial Group raised Clorox from a “hold” rating to a “buy” rating and increased their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Deutsche Bank Aktiengesellschaft boosted their price objective on Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Finally, TD Cowen upgraded Clorox from a “sell” rating to a “hold” rating and upped their price objective for the company from $155.00 to $170.00 in a research note on Wednesday, November 6th. Five equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $155.00.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.